| by admin | No comments

Huadian International (600027): Heating business drags down revenue growth and cost-side improvement is lower than expected

Huadian International (600027): Heating business drags down revenue growth and cost-side improvement is lower than expected Event: On April 26, Huadian International announced its 2019 quarterly report. In Q1 2019, the company achieved operating income of 233. 8 billion, an annual increase of 4. 04%, realizing net profit attributable to mother 7. 74 ppm, an […]

Read More
| by admin | No comments

Kangda New Materials (002669): Adhesive profit rises and Q1 performance forecast

Kangda New Materials (002669): Adhesive profit rises and Q1 performance forecast Event: The company issued a 19-year Q1 performance forecast. In the report period, the company realized a net profit of 2480. 25-2678. 680,000 yuan, + 150- + 170%; the company revised its performance forecast, and gradually predicted that the company’s Q1 attributable parent net […]

Read More
| by admin | No comments

Yangtze River Power (600900) 2019 Annual Report Commentary: Incoming water is too abundant to drive revenue growth and interest rate steadily declines

Yangtze River Power (600900) 2019 Annual Report Commentary: Incoming water is too abundant to drive revenue growth and interest rate steadily declines Event: On August 30, the company announced the 2019 interim report and realized operating income of 203.63 ppm, a six-year increase of 6.00%; net profit attributable to mother 85.72 ppm, an increase of […]

Read More
| by admin | No comments

Hengrui Medicine (600276): PD-1 new indication applied for leading indication layout

Hengrui Medicine (600276): PD-1 new indication applied for leading indication layout Event On September 12, Hengrui Pharmaceutical issued an announcement that the company’s Carrelizumab single-line second-line indication for esophageal cancer and combined first-line therapy combined with chemotherapy received a CDE supplementary review. According to Hengrui’s current clinical indications for each indication,The progress of the trial, […]

Read More
| by admin | No comments

Health Yuan (600380): steady growth in performance, waiting for the volume of alternative preparations

Health Yuan (600380): steady growth in performance, waiting for the volume of alternative preparations This report reads: The company announced the 2019 semi-annual report, which is in line with our performance outlook. The company’s extraction preparations entered the harvest period, and the profitability gradually improved, maintaining the company’s overweight rating. Investment Highlights: Maintain Overweight rating. […]

Read More
| by admin | No comments

Xishan Coal and Electricity (000983): Increasing equity in Jinxing Energy boosts performance growth

Xishan Coal and Electricity (000983): Increasing equity in Jinxing Energy boosts performance growth Summary and recommendations: The company released the third quarter results announcement for the first three quarters of 19, achieving revenue of 246 in the first three quarters.600 million yuan, a year-on-year increase of +5.5%, recorded net profit 南宁桑拿 attributable to mother 18.100 […]

Read More
| by admin | No comments

Fengyuan (002805): Supply and demand of oxalic acid is rapidly advancing to lithium-ion transition materials.

Fengyuan (002805): Supply and demand of oxalic acid is rapidly advancing to lithium-ion transition materials. Event: The company released its 2018 annual report and achieved operating income2. 6.5 billion, previously -17. 48%, net profit attributable to mother is 1630. 890,000 yuan, at least -56. 97%. The domestic market for oxalic acid in 2018 was affected […]

Read More
| by admin | No comments

Ping An of China (601318) Semi-annual Report 2019 Review: NBVM Continues to Increase Tax Cuts and Investment to Improve Thickening Results

Ping An of China (601318) Semi-annual Report 2019 Review: NBVM Continues to Increase Tax Cuts and Investment to Improve Thickening Results 1. The event company released its semi-annual financial report for 2019. 2. Our analysis and judgments 1) Benefiting from the effect of tax reduction + investment income, the growth of net profit increased by […]

Read More
| by admin | No comments

SF Holdings (002352) Company Research: Deducting Non-Net Profits, Speeding Up, Continue to Be Optimistic about New Business Development

SF Holdings (002352) Company Research: Deducting Non-Net Profits, Speeding Up, Continue to Be Optimistic about New Business Development Event: SF Holdings released the third quarter report of 2019.The first three quarters of 2019 achieved operating income of 787.7 ppm, an increase of 20 in ten years.37%, net profit attributable to mother 43.110,000 yuan, an increase […]

Read More
| by admin | No comments

Ninghu Expressway (600377): Steady growth in toll collection business of road property Real estate gradually releases performance

Ninghu Expressway (600377): Steady growth in toll collection business of road property Real estate gradually releases performance Investment Highlights: News / Announcement: The company released its 2018 annual report. In 2018, Nanjing-Shanghai Expressway achieved a total of 99 operating income. 69 ppm, a five-year increase of 5. 43%, net profit attributable to mother 43. 77 […]

Read More